Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Genenta Science SpA

GNTA ✗ NOT COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$0.72

▼ -3.85%

Market Cap $17.03M · Vol 4.04K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$17.03M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

57.13

Momentum

Beta

0.99

vs Market

52W High

$10.00

92.78% below

52W Low

$0.56

29.74% above

Volume

4.04K

Avg 5.52K

P/B

1.36

Price-to-book

ROE

N/A

Return on equity

Free Float

56.49%

Public shares

Shariah Compliance8 STANDARDS

✗ Genenta Science SpA (GNTA) stock is currently not Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GNTA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.90%

-14.13%

-45.30%

+12.36%

YTD

-51.54%

-79.19%

-87.11%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-7,669,251.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-27.96% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	1.36
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	23.59M

Technical Indicators

50-Day SMA	$0.96
200-Day SMA	$1.09
RSI (14)	57.13
Beta	0.99
52-Week High	$10.00
52-Week Low	$0.56

Volume Today	4.04K
Avg Daily Volume (30D)	5.52K
Relative Volume	0.73x
Volatility (10D)	117.93
Volatility (30D)	96.52
Free Float	56.49%

Analyst Consensus

N/A

Current Price $0.72

Mean Target N/A

52W Low$0.56 52W High$10.00

Current

Target

$0.56 $10.00

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG013GNLKF0

ISINUS36870W1009

CountryItaly

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.32% ONC BeOne Medicines AG -0.38% 068270.KS Celltrion, Inc. -0.39% MEDP Medpace Holdings, Inc. -1.64% ABVX Abivax SA -0.83%

Company Profile

Genenta Science SpA is an Italy-based company active in the biotechnology, aerospace, defense, and national security sectors. Within its biotechnology activities, the Company's platform Temferon focuses on hematopoietic stem and progenitor cells (HSPCs) engineered to deliver therapeutic genes and modulate immune responses. Regarding the aerospace and defense sector, through Sophia High Tech S.r.l., the Company is involved in the design, engineering, prototyping, and manufacturing of mechanical components for aerospace and defense applications. Through ATC (Armi Tattiche Custom), Genenta Science SpA is engaged in the manufacturing of tactical systems and related components. Its product portfolio includes tactical rifles, chassis systems, optics mounts, bipods, and accessories. Genenta Science SpA's activities also include the acquisition of majority or full ownership interests in privately held companies operating in sectors subject to Italy's national security regulations.